Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024)
Avricore Health (AVCRF) posted quarterly Non Operating Investment Income of -$131688.6 for Q3 2024, up 38.07% year-over-year from -$95379.1 in Q4 2023, and up 38.07% quarter-over-quarter from -$212636.4 in Q3 2023.
Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Avricore Health (AVCRF) has reported Non Operating Investment Income for 2 consecutive years, with -$131688.6 the latest figure, recorded in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -131,688.62 |
| Sep 30, 2024 | -131,688.62 |
| Sep 30, 2023 | -212,636.43 |
| Sep 30, 2023 | -212,636.43 |